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1  | INTRODUC TION
Bacteria have exquisite abilities to respond to environmental condi-
tions carefully balancing the benefits of a response against the asso-
ciated metabolic cost. The importance of this is particularly evident 
in the context of antibiotic resistance, where one of the main coun-
teracting forces working against the development and spread of 
resistance is the associated cost in fitness (Andersson and Hughes, 
2010; Durão et al., 2018; Waglechner and Wright, 2017). To minimize 
this cost, many resistance determinants are tightly regulated, which 
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Abstract
Bacteria closely control gene expression to ensure optimal physiological responses 
to their environment. Such careful gene expression can minimize the fitness cost as-
sociated with antibiotic resistance. We previously described a novel regulatory logic 
in Bacillus subtilis enabling the cell to directly monitor its need for detoxification. This 
cost-effective strategy is achieved via a two-component regulatory system (BceRS) 
working in a sensory complex with an ABC-transporter (BceAB), together acting as a 
flux-sensor where signaling is proportional to transport activity. How this is realized 
at the molecular level has remained unknown. Using experimentation and computa-
tion we here show that the histidine kinase is activated by piston-like displacements 
in the membrane, which are converted to helical rotations in the catalytic core via an 
intervening HAMP-like domain. Intriguingly, the transporter was not only required 
for kinase activation, but also to actively maintain the kinase in its inactive state 
in the absence of antibiotics. Such coupling of kinase activity to that of the trans-
porter ensures the complete control required for transport flux-dependent signal-
ing. Moreover, we show that the transporter likely conserves energy by signaling 
with sub-maximal sensitivity. These results provide the first mechanistic insights into 
transport flux-dependent signaling, a unique strategy for energy-efficient decision 
making.
K E Y W O R D S
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requires that the bacterium is able to accurately determine the se-
verity of an antibiotic attack and adjust gene expression accordingly. 
We previously described a new sensory strategy in Bacillus subtilis 
that produces an exquisitely fine-tuned response, with three orders 
of magnitude of output modulation over an input dynamic range of 
three orders of magnitude (Fritz et al., 2015). This regulatory logic is 
achieved by a two-component system (BceRS) whose histidine ki-
nase, BceS, works in a sensory complex with an ABC-transporter, 
BceAB (Dintner et al., 2014; Fritz et al., 2015) (Figure 1). BceRS con-
trols expression of the bceAB operon, and the resulting increased 
production of the transporter provides resistance against the pep-
tide antibiotic bacitracin (Ohki et al., 2003). A defining characteristic 
of this system is that the histidine kinase lacks any apparent sensory 
domains and instead requires the transporter for activation in re-
sponse to bacitracin (Hiron et al., 2011; Rietkötter et al., 2008).
Such systems are wide-spread among low G + C content Gram-
positive bacteria, including bacilli, lactobacilli, staphylococci, strep-
tococci, enterococci, and clostridia (Dintner et al., 2011; Gebhard 
et al., 2014; Hiron et al., 2011; Ouyang et al., 2010; Revilla-Guarinos 
et al., 2013; Staroń et al., 2011). They are collectively referred to as 
Bce-like systems and impart resistance against a broad range of cell 
wall-active peptide antibiotics (Gebhard and Mascher, 2011; Revilla-
Guarinos et al., 2014). Based on computational modeling of the re-
sponse dynamics in the B. subtilis Bce system, we have established 
that signaling is proportional to transport activity (Fritz et al., 2015). 
Because the transporter mediates the actual resistance, presumably 
by removal of the antibiotic from its target in the cell envelope (Fritz 
et al., 2015; Gebhard, 2012; Greene et al., 2018; Kobras et al., 2020), 
increased transporter production acts a negative feedback on sig-
naling, which creates the characteristic gradual, fine-tuned response 
(Fritz et al., 2015). This flux-sensing mechanism effectively allows 
the bacterium to adjust its response according to its need for ad-
ditional detoxification capacity, implementing a cost-effective “pro-
duce-to-demand” strategy. However, the molecular mechanism of 
this new signaling strategy, that is, how the activity of the histidine 
kinase is controlled within the sensory complex and how this creates 
the observed analog response behavior, remains unknown.
Histidine kinases typically relay extracellular information to the 
cytoplasm via autophosphorylation at a conserved histidine resi-
due, which then leads to phosphorylation of a cytoplasmic response 
regulator that elicits changes in gene expression (Gao and Stock, 
2009). Despite their importance in bacterial signaling, we still have 
limited understanding of the molecular mechanisms by which his-
tidine kinases transmit information through the cytoplasmic mem-
brane. This is in part due to the modular architecture of the kinases, 
which allows a plethora of different input domains to be coupled to 
a conserved catalytic core. The core consists of a DHp (also known 
as HisKA) domain that facilitates dimerization and histidine phos-
photransfer, and a C-terminal ATPase domain (Gao and Stock, 2009). 
The extracellular input and cytoplasmic core domains are separated 
F I G U R E  1   Function of the BceRS-BceAB resistance system of B. subtilis. BceS and its domains are shown in shades of blue, with the 
HAMP-like domain in dark turquoise, and DHp domain in dark blue. Only a single monomer of BceS is shown for clarity. The BceB permease 
is in bright green with the eighth transmembrane helix marked in dark green and the extracellular domain indicated by a green crescent; two 
molecules of the ATPase BceA are shown in pale green associated with the BceB monomer, according to the A2B stoichiometry (Dintner 
et al., 2014). The left section of the schematic shows the system in its inactive (OFF) state, and the repressing function of the transporter 
indicated by a red blunt arrow. The right shows the active (ON) state in the presence of antibiotics, exemplified by bacitracin, with the 
activating function of the transporter shown as a red lightning bolt. The motions of kinase domains upon activation are shown as red block 
arrows and BceS autophosphorylation by a ‘P’. The positioning of the symbols within the sensory complex for repression/activation is 
arbitrary. ATP hydrolysis reactions and antibiotic removal are indicated by grey arrows; for simplicity ATP hydrolysis is only shown for one 
ATPase
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by transmembrane segments and usually at least one cytoplasmic 
signal transfer domain (e.g., HAMP or PAS domains) (Gao and Stock, 
2009; Gushchin et al., 2017). Recent studies of histidine kinase do-
mains in isolation or together with an adjacent domain suggest that 
transmembrane signaling can occur via rotating and scissoring mo-
tions and piston-like helical displacements of transmembrane helices 
(Bhate et al., 2015; 2018; Gushchin et al., 2017; Monzel and Unden, 
2015). The nature of transmembrane motions largely appears to de-
pend on their context with sensory and signal transfer domains, al-
though the individual motions are not mutually exclusive (Gushchin 
and Gordeliy, 2017; Jacob-Dubuisson et al., 2018).
Additionally, several kinases are controlled by accessory pro-
teins. In many cases, these accessory proteins are transporters 
(Piepenbreier et al., 2017; Tetsch and Jung, 2009), and most act as 
repressors of kinase activity, with deletion of the transporter caus-
ing constitutive activation of signaling (Hsieh and Wanner, 2010; 
Unden et al., 2016; Witan et al., 2012). The flux-sensing Bce-like 
systems are unique in that the histidine kinases fully rely on their 
cognate transporters for activation, and remain inactive when the 
transporter is deleted (Gebhard and Mascher, 2011; Rietkötter 
et al., 2008). Moreover, implementing the reported flux-sensing 
strategy requires kinase activity to be directly proportional to trans-
port activity (Fritz et al., 2015). To our knowledge, no information is 
available on how accessory proteins may achieve such positive and 
precise control over a histidine kinase.
In the present study, we sought to understand the mechanis-
tic basis of histidine kinase activation in the Bce system of Bacillus 
subtilis and how this links to the system's analog signaling behavior. 
Through computational predictions, detailed mutagenesis and cys-
teine crosslinking and accessibility analyses, we provide evidence 
that the kinase BceS is activated via helical rotations in the DHp do-
main, accompanied by a piston movement in the second transmem-
brane domain. Physical motions are most likely relayed via a poorly 
conserved intervening HAMP-like domain. We also show that the 
transporter not only acts as the activator of the kinase, but also con-
trols its inactive state. We propose it is this complete control over ki-
nase conformation that couples its activity to that of the transporter. 
Surprisingly, mutagenesis of the putative signaling domain of the 
F I G U R E  2   The BceS DHp domain forms a four-helix bundle. (a) Homology model of the BceS HAMP-like and DHp domains generated by 
I-TASSER (C-score = −0.76). The HAMP-like domain is shown in purple and the DHp domain in blue. The residues that form Cys-crosslinks 
in panel b are highlighted, E115 (red), E118 (purple) and L119 (green). Residue K167, which sits opposite E115, is shown in orange. (b) 
Percentage of crosslinking for each BceS Cys variant was calculated from relative band intensities between monomer and dimer within 
each lane using Fiji (Schindelin et al., 2012). Amino acid substitutions were introduced in parent construct bceSWT-His8 (SGB369) and BceS 
production was controlled by addition of 0.02% (w/v) xylose. Data are shown as mean ± SD from two to five independent repeats. (c, d) 
Schematic diagram of the BceS DHp dimer configuration. Helices labeled DHp1’ and DHp2’ show the second protomer. Left, top down 
view of the helices in the structural model; right, helical wheel diagram of the top two helical turns in the DHp domain; residues that form 
crosslinks are highlighted as before
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transporter, BceAB, highlighted that the system has not evolved for 
maximal signaling sensitivity, which likely represents an additional 
layer of fine-tuning and energy conservation.
2  | RESULTS
2.1 | Generation and validation of a BceS homology 
model
Analysis of the domain architecture of BceS using SMART (Letunic 
et al., 2012) showed two N-terminal transmembrane helices, predicted 
to end at residue F55, and a prototypical cytoplasmic kinase core with 
a DHp domain from residues E115 to I172 and ATPase domain from 
S216 to N326. The 60 amino acid linker between the transmembrane 
and DHp domains contained no predicted domains. To investigate the 
cytoplasmic composition of BceS in more detail, we used I-TASSER 
(Zhang, 2008) to predict the tertiary structure of the linker region 
and DHp domain (residues R56 to N174; Figure 2a). The closest struc-
tural analog was a hybrid protein consisting of the HAMP domain of 
Af1503A291V from Archaeoglobus fulgidus and the DHp domain of E. coli 
EnvZ (PDB 3ZRW; see methods for quality scores), which shares 20% 
sequence identity and 40% similarity with the BceS fragment used for 
structure prediction. The homology model of BceS showed the typical 
DHp domain fold of two antiparallel helices (DHp1 and DHp2), joined 
by a short loop. In the functional kinase dimer, this will form the four-
helix bundle characteristic for most histidine kinases (Gao and Stock, 
2009) (Figure 2c). Interestingly, the linker between the membrane in-
terface and DHp domain adopted a HAMP-like conformation with two 
short parallel helices (HAMP-like 1 and HAMP-like 2), where HAMP-
like 2 continues into DHp1 as a single continuous helix (Figure 2a). The 
relevance of this domain, which had not been predicted in previous 
analyses (Dintner et al., 2011; Mascher, 2006), is discussed in more de-
tail below. It should be noted that confidence in the exact conformation 
of the loops linking the two helices in the HAMP-like domain, and the 
short loop linking the two DHp domain helices is low in the homology 
model due to the presence of Ramachandran outliers (see Methods). 
However, the overall model still provided a plausible illustration of the 
BceS structure and was used to inform further experimental design.
To test the accuracy of the homology model, we probed the 
relative orientation of helices within the DHp domain four-helix 
bundle, based on proximity of individual residues, using oxidative 
cysteine crosslinking. These experiments were done in vivo using 
cells deleted for the native copy of bceS and carrying a single-copy 
ectopic construct for expression of bceS with a C-terminal His8-tag, 
allowing slight over-production of the kinase to facilitate detection 
by Western blot analysis. BceS contains three native Cys residues, 
C45 in the second transmembrane helix and C198 and C259 in the 
ATPase domain. Based on their physical distance from each other 
and the DHp domain, we did not expect these residues to interfere 
with our analysis, and indeed no crosslinking product was observed 
upon oxidation with iodine in wild-type BceS (Figure 2b). Next, single 
cysteine substitutions were introduced in the first two helical turns 
of the helix DHp1 (N114 to M120), and in equivalent positions near 
the end of the helix DHp2 (Q166 to R168). Disulfide bond forma-
tion in these variants should only occur if the substituted residues 
come into close proximity in the kinase dimer (Pakula and Simon, 
1992). The only residues that consistently formed detectable cross-
links were at positions 115, 118, and 119, with the highest degree of 
crosslinking at position 115 (Figure 2b). This is in good agreement 
with their positioning at the core of the four-helix bundle and shows 
that the structural model closely reflects the conformation of BceS 
in the cell (Figure 2c).
To ensure that the introduction of cysteines had not affected the 
integrity of the protein, we tested the activity of each BceS variant 
in vivo. This was based on their ability to induce expression from the 
system's target promoter fused to a reporter gene (PbceA-luxABCDE 
or PbceA-lacZ), following exposure to the antibiotic bacitracin (Fritz 
et al., 2015). Only the K116C and K167C substitutions led to a com-
plete loss of activity (Figure S1a). It is, therefore, possible that the 
lack of crosslinking observed for the latter, which also faces the core 
of the DHp domain (Figure 2c), could be explained by defects in the 
protein rather than the distance between DHp2 helices in the kinase 
dimer.
2.2 | Charge substitutions in the DHp core suggest 
a rotation mechanism of kinase activation
Inspection of the DHp domain revealed a striking concentration of 
charged residues at the membrane-proximal end of the four-helix 
bundle (Figure 3). In the wild-type kinase, E115 and K167 create a net 
neutral charge in the bundle core. As described above and previously 
(Fritz et al., 2015), cells harboring wild-type BceS strongly activate 
expression of the PbceA-lux reporter in the presence of bacitracin, 
while in the absence of the antibiotic the activity of the reporter is 
below the detection limit (Figure 3a, WT). Interestingly, creation of 
an “all negative” (K167D substitution) or “all positive” (E115K substi-
tution) DHp core resulted in a strong increase in the basal level of 
the kinase, while the activity in the presence of the inducer remained 
unaffected (Figure 3a). To test whether this effect was, indeed, due 
to the changes in core charge and not to substitutions at this posi-
tion per se, we introduced a series of other amino acids into posi-
tion 115. Exchanging E115 for a different positively charged amino 
acid, Arg, again resulted in an increase in basal activity, although less 
pronounced (Figure S1c). Substitution for Ala or Cys had no detect-
able effect on activity, showing that the presence of charged amino 
acids was not in itself important for kinase function. This is consist-
ent with the high density of charged residues in this part of BceS not 
being conserved among its homologues ((Dintner et al., 2011) and 
data not shown). Moreover, the constitutive kinase activity could be 
returned to near wild-type levels by restoring the net neutral charge 
through combining the E115K and K167D substitutions (Figure 3a). 
We, therefore, concluded that the high constitutive activity in the 
absence of the inducer was indeed due to the presence of four resi-
dues with the same charge in the DHp domain core.
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In the current model for histidine kinase activation, the DHp do-
main undergoes a helical rotation (Gushchin et al., 2017). The strong 
activating effect we observed upon introduction of four residues 
of the same charge at the core of the domain made it tempting to 
speculate that charge repulsion may force BceS to undergo such a 
rotating motion, placing it in its activated state. According to our 
homology model, rotation of the helix DHp1 in a counter-clockwise 
direction and DHp2 in clockwise should create two new points of 
contact between charged residues: point I between E118 and K167, 
and point II between K116 and R168 (Figure 3b). The opposing 
charges in point I should have a stabilizing effect on the rotated state, 
and removing this in the K167D variant may explain its lower basal 
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activity compared to E115K (Figure 3a). In contrast, the proximity of 
two positive charges in point II should have a de-stabilizing effect. 
Replacing one of these with a negative charge (K116E) by itself had 
no effect on kinase activity. However, combining K116E with the 
activating effect of the E115K substitution led to a further increase 
of basal kinase activity compared to E115K alone (Figure 3a). This 
effect is entirely consistent with kinase activation through helical 
rotations in the DHp domain, where we could achieve the highest ar-
tificial activation of the protein through creating charge repulsion in 
the kinase core, while stabilizing the rotated state through opposing 
charges in the two new points of contact.
Attempts were made to detect this DHp domain rotation in vivo 
using cysteine crosslinking, either following induction with baci-
tracin or using the constitutively active E115K/K116E variant. No 
quantitative conclusions could be drawn, however, due to the very 
large experimental errors (Figure S2). To provide further evidence 
of conformational change in the DHp domain, we turned to molec-
ular dynamics (MD) simulations. As discussed above, the homology 
model (Figure 2) shows excellent agreement with experimental 
validation, indicating that it is a reasonable starting point for MD 
simulations. Given the relatively large putative rotation, we applied 
Gaussian accelerated MD (GaMD) to more completely sample con-
formational space (Miao et al., 2015).
To assess conformational differences in the DHp domain be-
tween the wild-type kinase and the constitutively active E115K/
K116E variant, GaMD simulations were performed on both for a 
total of 2 µs each (four replicas of 500 ns; Figure S3a). From our sim-
ulations, we calculated the potential of mean force (PMF) for a series 
of internuclear distances for both wild-type and variant residues, to 
serve as a proxy for the energetic barrier between conformational 
sub-states. To best illustrate the relative orientation of helices in the 
DHp domain bundle, we focused on positions 115 and 167, facing 
the bundle core (Figure 3). The PMF plots for the internuclear pairs 
of these residues between monomeric units of the DHp domain are 
shown in Figure 3c. The lower the PMF value, the more likely the 
helices will occupy the conformational state defined by the internu-
clear distances shown. In the wild-type DHp domain, the PMF plot 
for distances between monomers at amino acids 115 and 167 shows 
a broad minimum across most of conformational space (Figure 3c, 
left). This suggests that there is a relatively high propensity for the 
domain to explore a diversity of conformational space. Figure 3c 
(right) shows the same data for the variant DHp, which, instead of 
the broad minimum, now shows two distinct, more restricted min-
ima. More specifically, the tendency toward a longer K167 distance 
in the variant would seem consistent with our model for helix rota-
tion (Figure 3b). To more clearly explore the differences between 
conformational space accessed, we performed principal components 
analysis (PCA) of the data from Figure 3c. This indicates that there 
is a significant difference in the principal component space sampled 
(Figure S3b), meaning the variant DHp occupies a conformational 
space that is not accessible to the wild-type domain. Based on the 
high constitutive activity of the variant, it is plausible to assume that 
this new conformational space represents the active state of the ki-
nase. Importantly, our simulations show that the wild-type kinase is 
unable to adopt this conformation on the simulated time scales. This 
is consistent with our in vivo data that shows no detectable kinase 
activity without activation through the transporter.
2.3 | BceS contains a HAMP-like signal 
transfer domain
Contrary to previous predictions (Dintner et al., 2011; 
Mascher, 2006), the BceS homology model showed a domain with 
structural similarity to a HAMP domain between the second trans-
membrane helix and the DHp domain. HAMP domains adopt a paral-
lel four-helix bundle arrangement with two alternative states of helix 
packing that transmit a conformational change from an upstream 
input to a downstream output domain by turning various input 
movements consistently into helical rotation (Gushchin et al., 2017; 
Hulko et al., 2006; Lai and Parkinson, 2014). The four-helix bundle is 
stabilized through multiple packing layers, predominantly mediated 
by hydrophobic residues (Hulko et al., 2006; Zhou et al., 2011). A se-
quence alignment of known HAMP domains and the HAMP-like do-
main of BceS is shown in Figure 4a, with the positions of the critical 
packing points highlighted. The hydrophobicity at these positions is 
largely conserved in BceS, with the exception of two positions occu-
pied by negatively charged Glu instead. Additionally, the conserved 
Pro residue in helix 1, and Glu in helix 2, typical for HAMP domains, 
are not present in BceS (Figure 4a).
Previous investigations of HAMP domains have highlighted one 
particular residue with key influence on the signaling state, most 
F I G U R E  3   Charges within the BceS DHp domain core affect kinase activity. (a) BceS signaling activity in strains harboring PbceA-
luxABCDE and Pxyl-bceS. Amino acid substitutions were introduced in parent construct bceS
WT-His8 (SGB369). Signaling was induced with 1 
µg/ml of bacitracin. Data are shown as mean ± SD from 4–22 biological repeats. The schematic below shows the location of individual and 
net charges in the core and stabilization points within the four-helix bundle, as illustrated in panel b. Red, positive charge; orange, negative 
charge. Unpaired t-test comparison to WT showed significant differences (p < .0001) in the absence of bacitracin for all variants except 
K116E (p = .8), and no significant differences (p > .1) in the presence of bacitracin for all variants, except K116E (p = .04). Differences with 
versus without bacitracin were significant (p < .005) in all strains. (b) Helical wheel diagram of the top two helical turns in the DHp dimer 
configuration showing location of charges and stabilization points (pink and cyan). Helices labelled DHp1’ and DHp2’ show the second 
protomer. Grey curved arrows denote the direction of helical rotation. For orientation, the distance between residues at position 115 is 
likely to be in the range of 4–12 Å based on our cysteine crosslinking results. (c) 2D plots of potential of mean force (PMF) obtained in GaMD 
simulations of the wild type (WT, left) and E115K/K116E variant (right) protein. Inter-monomer distances shown are between the Cα carbon 
atoms of residues at positions 115 (x-axes) and 167 (y-axes). The PMFs are projected onto the surface in kcal/mol indicated by the heat scale
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F I G U R E  4   BceS contains a HAMP-like signal transfer domain. (a) Sequence alignment of known HAMP domains and the BceS HAMP-
like domain generated with ClustalO. Residues in red form the packing layers in the Af1503 HAMP domain. The black solid arrow indicates 
the packing residue that influences signaling state in some HAMP domains. White open arrows indicate E60 and F63 critical for BceS 
function. Proteins included and their GenBank identifiers are Af1503 (O28769), BceS (BSU30390), PhoQ (P23837), CpxA (P0AE82), EnvZ 
(P0AEJ4), NarX (P0AFA2), Tsr (P02942), Tar (P07017), Aer (P50466). (b) Schematic showing amino acids and their sizes in MW used in size 
substitutions. (c), BceS signaling activity following L67 amino acid size substitution harboring PbceA-luxABCDE and Pxyl-bceS. Amino acid 
substitutions were introduced in the parent construct bceSWT-His8 (SGB369). Signaling was induced with 1 µg/ml of bacitracin. Data are 
shown as mean ± SD from 3–18 biological repeats. **, significant difference (p < .01) in activity compared to WT construct, determined 
by unpaired t-test; ns, not significant; in the absence of bacitracin, no significant differences were detected. (d) Helical wheel diagram of 
the HAMP-like domain. Individual helices are abbreviated HL-1 and HL-2; the labels HL-1’ and HL-2’ show the second protomer. Residues 
essential for BceS activity are E60 (red) and F63 (yellow); the key packing residue L67 is shown in blue; red/blue semicircles are used to 
indicate positioning of residues in subsequent helical layers. (e), BceS signaling activity of the constitutive ON variant (BceSE115K) combined 
with loss-of-function substitutions at positions 60 and 63. Amino acid substitutions were introduced in parent construct bceSWT-His8 
(SGB401). Signaling in cells harboring PbceA-lacZ and Pxyl-bceS was induced with 1 µg/ml of bacitracin, BceS production was controlled by 
addition of 0.02% (w/v) xylose. Signaling is reported as β-galactosidase activity in Miller units, and data are shown as mean ± SD from 3–7 
biological repeats. The inset shows an anti-His Western blot analysis to confirm membrane localization and protein levels of wild-type (WT) 
BceS and its variants
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commonly occupied by small hydrophobic residues that favor bun-
dle packing (Hulko et al., 2006). This residue corresponds to L67 
in BceS (Figure 4a, black arrow). Based on structural work on the 
HAMP domain of the A. fulgidus protein Af1503, this residue (A291 
in Af1503) is crucial in controlling the domain's conformational state. 
Specifically, it is thought that increasing residue size at this position 
decreases the threshold for conversion between packing states and 
can cause increased signal responsiveness or elevated kinase activ-
ity, while smaller residues decrease activity (Ferris et al., 2011, 2012; 
Hulko et al., 2006; Matamouros et al., 2015).
To test if the HAMP-like domain in BceS fulfils an equivalent func-
tion to bona fide HAMP domains, we, therefore, investigated the role of 
amino acid size at this position by changing L67 to the smaller Gly and 
Cys, as well as the larger Phe (Figure 4b). Indeed, smaller size substi-
tutions reduced BceS activity, up to a near-complete loss of induction 
in the Gly variant (Figure 4c). Increasing the size to Phe, however, did 
not lead to an increase of signaling nor basal activity of BceS. This is 
consistent with small residues potentially increasing the threshold for 
conversion between domain conformations (Ferris et al., 2011; Hulko 
et al., 2006), but we could not find a stimulating effect through a larger 
residue. We nevertheless conclude that the HAMP-like domain in BceS 
is likely a functional equivalent to conventional HAMP domains in other 
proteins contributing to signal transfer within the histidine kinase.
For further functional investigation, we carried out Cys scanning 
mutagenesis of the HAMP-like domain. The majority of variants 
maintained at least partial signaling activity (Figure S4), and in con-
trast to other studies (Appleman and Stewart, 2003; Matamouros 
et al., 2015), we did not find any substitutions that led to constitutive 
activation. The only two substitutions that caused a complete loss of 
function were E60C and F63C (Figures 4 and S4). Interestingly, these 
fall on the first two positions of the packing motif (Figure 4a, white 
arrows and Figure 4d), with E60 located one packing layer above 
the critical L67 discussed earlier, and are, therefore, likely of struc-
tural importance. Both variant proteins are present in the cytoplas-
mic membrane at the same levels as the wild-type protein according 
to Western blot analysis (Figure 4e inset), showing that the lack of 
signaling is not caused by general protein misfolding. To test if the 
defect of the two variants was due to a loss of signal transfer from 
either the membrane region of the protein or the transporter, we 
combined each of the LOF mutations with the E115K substitution 
that constitutively activates BceS. All resulting variants remained 
inactive (Figure 4e), suggesting that the substitutions in the HAMP-
like domain likely caused structural disruptions, rather than specifi-
cally affecting signal transfer.
2.4 | Activation of BceS involves a piston-like 
displacement in transmembrane helix 2
We next investigated the conformation of the second transmem-
brane helix in BceS. In many histidine kinases, conformational 
changes in an extracellular sensory domain are transmitted to the 
cytoplasmic region through physical movement of the intervening 
transmembrane helix (Gao and Stock, 2009). In the case of BceS, 
however, signaling is entirely reliant on the BceAB transport system, 
and therefore does not involve canonical transmembrane informa-
tion transfer. To investigate if BceS activation nevertheless involved 
transmembrane helix movements, we carried out a cysteine acces-
sibility scan (Scan-SCAM, (Monzel and Unden, 2015)) of its second 
transmembrane helix. This analysis requires a cysteine-free back-
ground, and we, therefore, replaced the three native Cys residues 
mentioned earlier by serine and confirmed that he C45S/C198S/
C259S BceS variant was still fully functional (Figure S5). Individual 
cysteine replacements were done from positions 51 to 65, surround-
ing the predicted membrane interface at W54 or F55. The essential 
residues E60 and F63 were not replaced. All variants were signaling 
competent (Figure S5).
The position relative to the membrane was then tested for each 
Cys residue based on its solvent accessibility, using a modified ver-
sion of the established E. coli protocol (Monzel and Unden, 2015). In 
brief, treatment of whole cells with N-ethyl-maleimide (NEM) should 
block any solvent-exposed Cys residue, whereas in untreated cells 
the sulfhydryl groups should remain available for later reactions. 
Following isolation of membranes, any unblocked Cys residues are 
then reacted with methoxypolyethylene glycol maleimide (PEG-mal), 
resulting in a 10 kDa increase in size, detectable by Western Blotting. 
For cytoplasmic Cys residues in BceS, we, therefore, expected to see 
a shift in size only in samples that had not been treated with NEM 
(Figure 5, blue labels). In contrast to the established E. coli method-
ology (Monzel and Unden, 2015), we could not observe PEGylation 
of membrane-embedded Cys residues in B. subtilis, regardless of the 
presence of SDS, possibly due to differences in membrane composi-
tion. We, therefore, interpreted those residues as being membrane 
embedded that did not show a size shift in either presence or ab-
sence of NEM treatment (Figure 5, red labels).
Our results showed that residues up to position 56 resided in the 
solvent-inaccessible membrane environment, while residues from 
Y57 onward were accessible, and therefore cytoplasmic (Figure 5, 
“OFF state”). We then repeated the same analysis in the background 
of the E115K/K116E substitutions that place the kinase in a consti-
tutively active conformation. Here, residues from F55 onward be-
came consistently solvent-accessible (Figure 5, “ON state”), showing 
that BceS activation involved an inward piston-like displacement by 
two amino acids of the second transmembrane helix. An interesting 
observation was residue Y64, which labeled as inaccessible in the 
OFF state, despite being surrounded by solvent-exposed positions. 
It is likely that this residue is involved in protein-protein interactions, 
for example within BceS or potentially with BceB, that in the inactive 
state prevent its labeling through steric effects, as has been pro-
posed before (Monzel and Unden, 2015).
We next sought to test whether BceS could be activated by ar-
tificially inducing a shift through introduction of positively charged 
arginine residues near the membrane interface. This approach 
has been shown to cause signal-independent activation of the E. 
coli histidine kinase DcuS (Monzel and Unden, 2015). We, there-
fore, substituted three of the residues near the cytoplasmic end of 
     |  9KOH et al.
transmembrane helix 2 of BceS (W54, F55 and Y57) with Arg, indi-
vidually and in pairs. (Figure S6). Variants containing the W54R sub-
stitution had approximately 60% higher activities upon stimulation 
with bacitracin (Figure S6), which may indicate a stabilization of or 
lowered transition threshold to the activated state. However, none 
of the variants showed a detectable change of basal activity in the 
presence or absence of the input transporter BceAB, leading us to 
conclude that Arg substitution alone did not remove the strict reli-
ance on BceAB for signaling.
2.5 | The transporter BceAB has complete control 
over kinase conformation
It was previously shown for several Bce-like systems that signaling 
is completely reliant on the transporter (Gebhard et al., 2014; Hiron 
et al., 2011; Ouyang et al., 2010; Rietkötter et al., 2008; Staroń 
et al., 2011). We further showed through computational modeling 
that the signaling output via BceS is directly proportional to the ac-
tivity of BceAB and does not follow the switch-like on/off behavior 
seen in most other systems using transporters as accessory sens-
ing proteins (Fritz et al., 2015; Piepenbreier et al., 2017). This led 
us to hypothesize that BceAB completely controls the conformation 
of BceS within the sensory complex, and thus couples kinase activ-
ity directly to its own transport activity. Our discovery of the DHp 
domain variants that cause artificial activation of BceS now for the 
first time enabled us to test this hypothesis experimentally by inves-
tigating the role of BceAB in controlling the OFF state of the kinase.
In cells harboring the wild-type sequence of BceS, the OFF-state 
activity was below the detection limit of our assays, and deletion 
of the transporter, therefore, had no measurable effect (Figure 6). 
However, in the E115K or the E115K/K116E variants, basal kinase 
activity was high, allowing us to test the effect of bceAB deletion 
in the absence of bacitracin. Removing the transporter in this back-
ground caused a striking further increase in activity, rendering the 
kinase fully activated irrespective of the presence of the inducing 
F I G U R E  5   Accessibility of Cys residues at the membrane interface shows a piston-like displacement upon BceS activation. (a) Schematic 
representation of transmembrane helix 2 in the OFF and ON states, respectively. Relevant native amino acids are indicated in one-letter 
code. Solvent-accessible (PEGylated) Cys replacements are shown in blue, inaccessible (unPEGylated) Cys replacements in red and residues 
not tested in white. Residues circled in black were tested in triplicate, those circled in grey in duplicate. (b) Anti-His Western blot analysis of 
solvent-accessibility of Cys replacements (Scan-SCAM). Bands corresponding to PEGylated (S-PEG) and unmodified (S) BceS are indicated; 
individual lanes are outlined in the same color code as used in panel a. “Cys-less” indicates the parent variant of BceS lacking its native Cys 
residues. OFF state: amino acids substituted in parent construct bceSC45S/C198S/C259S-His8 (SGB936). ON state: amino acids substituted in 
parent construct bceSE115K/K116E/C45S/C198S/C259S-His8 (SGB951)
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antibiotic (Figure 6). Therefore, the inactive transporter can inhibit 
the activity of the constitutively active DHp domain variants ap-
proximately 10-fold. Our data are consistent with a model where 
inactive BceAB exerts close control over BceS keeping the kinase in 
its inactive state (Figure 1, left). This reveals a further layer of kinase 
control in addition to the transporter's known activating effect, for 
example, preventing spurious signaling in the absence of antibiotics.
2.6 | BceAB has not evolved for maximal signaling 
sensitivity
Recent structural work has provided new insights into the functional 
mechanism of the Type VII superfamily of ABC transporters, to 
which BceAB belongs. They act as mechanotransmitters, using cyto-
plasmic ATP hydrolysis to provide energy for periplasmic processes, 
such as removal of antibiotics (Crow et al., 2017). In E. coli MacB, 
mechanotransmission is achieved by the transmembrane helix link-
ing the cytoplasmic ATPase interaction site to the periplasmic do-
main (Crow et al., 2017). In BceAB, the equivalent region is its eighth 
transmembrane helix (Figure 1, dark green) (Greene et al., 2018). 
Based on our earlier discovery that this region of BceB contained a 
particularly high density of mutations leading to a loss of signaling 
(Kallenberg et al., 2013), we speculated that this region was crucial 
for the communication between transporter and kinase. We, there-
fore, carried out another Cys scan of residues 533 to 556 in BceB, 
encompassing approximately half of transmembrane helix 8 and the 
first alpha-helical segment of the adjacent cytoplasmic region. The 
native Cys at position 544 was replaced by Ser. Expression of bceAB 
was from a xylose-inducible promoter for consistent transporter 
production irrespective of signaling activity. The resulting variants, 
except G535C, displayed comparable bacitracin resistance to the 
isogenic progenitor strain (Table S2), confirming full functionality of 
the transporters.
Signaling assays showed that all variants except G543C reached 
a similar amplitude of reporter induction as strains containing the 
wild-type construct (Figure S7). However, we observed some clear 
difference in the sensitivity of signaling, that is, the minimal concen-
tration of antibiotic required to elicit a response. In cells with the 
wild-type construct, the lowest bacitracin concentration to trig-
ger signaling was 3 µg/ml, while a number of variants had a higher 
threshold of 10 µg/ml (Figure 7, green vs. pink dots; Figure S7). The 
majority of these fell into the C-terminal part of the scanned region, 
indicating potential defects in coupling to the ATPase. Surprisingly, 
we found several variants that showed a marked increase in signaling 
sensitivity and responded already at 0.3 µg/ml or even 0.03 µg/ml 
bacitracin (Figure 7, dark blue dots; Figure S7). We had previously 
seen that a reduction of BceAB transport activity can cause such a 
shift in signaling threshold, because the negative feedback created 
by removal of the antibiotic is missing (Fritz et al., 2015). However, as 
none of these variants showed any change in resistance (Table S2), 
loss of antibiotic removal cannot explain the increased signaling 
sensitivity.
Residue mapping showed that they occurred with a regular 
periodicity of every four amino acids (Figure 7b), suggesting po-
sitions along the same face of the transmembrane helix. Figure 7c 
shows a homology model from I-TASSER of the final three trans-
membrane helices of BceB for illustration. Substitutions with the 
relatively small amino acid Cys may have enabled tighter helix 
packing, potentially contributing to more effective signaling. To 
test this, we replaced two of the positions, L546 and Q550, with 
a series of other amino acids, including small Ala; charged Glu or 
Asp; and large Phe. Regardless of the substitution, deviation from 
the wild-type sequence at these positions consistently led to an 
F I G U R E  6   Control of BceS activity by the transporter BceAB. Signaling activity of BceS was measured in strains harboring PbceA-
luxABCDE and challenged with 10 µg/ml of bacitracin (grey) or left untreated (black). Amino acid substitutions were introduced into parent 
construct Pxyl-bceS-His8, in a strain background carrying a ΔbceS deletion (BceAB +; SGB792), or a ΔbceSAB deletion (BceAB -; SGB818). 
Data are shown as mean ± SD from 5–12 biological repeats. Results from unpaired t-test are shown by brackets across the strains and 
conditions compared, analyzing basal and induced activities separately. ****, p < .0001; ***, p < .001; ns, p > .05. Differences with versus 
without bacitracin were significant (p < .005) in all strains
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F I G U R E  7   BceAB signals with sub-maximal sensitivity. Amino acid substitutions were introduced into the Pxyl-bceAB-FLAG3 parent 
construct and signaling assessed using either a PbceA-lacZ (SGB370 and derivatives) or PbceA-luxABCDE (SGB731 and derivatives) reporter. 
Cells were challenged with a series of bacitracin concentrations for 45 minutes, before signaling activities were determined. (a) Signaling 
phenotype of wild-type (WT) BceAB and representative variants (see Figure S7 for complete datasets). The colored dots indicate the type 
of signaling behavior as depicted in panel b (green, WT; blue, hypersensitive signaling; pink, defective signaling). Data are mean ± SD of 
triplicate experiments. (b) Distribution of signaling phenotypes along the transmembrane helix 8 of BceB. The same color symbols are 
used as in panel a, and the y-axis indicates the threshold bacitracin concentration giving signaling above background. For clarity, threshold 
concentrations below 0.3 µg/ml are not resolved. The first line of x-axis labels gives native amino acids, the lines below indicate substitutions 
tested. The bar above the graph shows positions in the BceB sequence and areas within the membrane (grey bar) or in the cytoplasm (black 
line). (c) Homology model of the C-terminal three transmembrane helices of BceB (from amino acid 507, C-score −0.66) generated using 
I-TASSER; the top structural analog was MacB of Acinetobacter baumanii (PDB 5WS4). Positions where amino acid substitutions caused 
increased signaling sensitivity are highlighted in blue. The approximate predicted membrane boundaries are indicated by a white dashed line
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increase in signaling sensitivity (Figure 7b). It is difficult to envis-
age that all substitutions caused tighter protein interactions. An 
alternative explanation may be that they are involved in coupling 
extracellular ligand binding to ATP hydrolysis, and that weakened 
coupling through the substitutions allowed signaling to occur at 
lower concentrations. Despite numerous genetic and biochemical 
attempts, the precise residues with which BceS and BceB interact 
remain unknown, likely due to an extensive interface between the 
proteins involving multiple contacts.
While it was beyond the scope of this study to pursue a further 
functional characterization of the transporter, our findings clearly 
show that BceB contains a series of residues that prevent signaling 
from occurring at lower bacitracin concentrations. Given that any 
replacement we tested led to more sensitive signaling, we, therefore, 
concluded that evolution of the transporter has actively avoided 
such hypersensitive signaling, constituting a further layer in minimiz-
ing the fitness cost of resistance. Under laboratory conditions, we 
have not yet been able to detect a competitive disadvantage from 
harboring hypersensitive variants of BceAB. However, fast growth in 
carefully controlled conditions is not representative of the complex 
microbial interactions in natural habitats, where energy-conserving 
regulatory strategies will likely contribute to the competitive success 
of a microorganism.
3  | DISCUSSION
In this study, we set out to investigate the molecular mechanisms 
of the flux-sensing strategy employed by Bce-like antibiotic resist-
ance systems. Their hallmark feature is that histidine kinase activ-
ity is directly proportional to transport activity across a large input 
dynamic range of antibiotic concentrations (Fritz et al., 2015). This 
careful adaptation of signaling ensures the resistance transporter is 
produced precisely to the cell's demand for detoxification capacity, 
a very cost-efficient strategy to control gene expression. The results 
presented here now provide molecular level understanding of how 
such close control over kinase activity can be achieved.
Analyses of BceS conformation in the inactive and active state 
showed a piston-like inward displacement of the second transmem-
brane helix upon kinase activation, associated with helical rotation 
within the DHp domain as inferred from mutagenesis analysis and 
GaMD simulations. Tertiary structure predictions and experimental 
validation indicate that BceS possesses an intervening HAMP-like 
domain that likely fulfils a signal transfer function.
While bacterial transmembrane histidine kinases have been 
studied for decades and we have a very good understanding of 
the function of the individual domains (reviewed in Gao and Stock, 
2009; Jacob-Dubuisson et al., 2018)), a complete understanding 
of how extracellular events (e.g., ligand binding) are transmitted to 
the cytoplasmic catalytic domains to trigger autophosphorylation 
is only beginning to emerge (Gushchin and Gordeliy, 2017; Jacob-
Dubuisson et al., 2018). In a canonical transmembrane histidine 
kinase, extracellular ligand binding causes conformational changes 
in the sensory domain, which will directly influence the transmem-
brane segments. Due to the diversity of sensory domains, there 
is also a diversity in the conformational changes received by the 
transmembrane helices. In the nitrate sensor NarQ of E. coli, for 
example, nitrate binding by the sensory domain causes a complex 
combination of a helical break between sensory and transmem-
brane domains with scissoring and twisting motions at the peri-
plasmic end of the membrane helices. The net result of this is a 
piston-shift displacement perpendicular to the membrane, which 
in turn elicits conformational changes in the adjacent cytoplas-
mic HAMP domain (Gushchin et al., 2017). In the E. coli kinases 
DcuS and CitA, binding of fumarate or citrate, respectively, by an 
extracellular PAS domain causes compaction of the sensory do-
main, which displaces the adjacent transmembrane helix toward 
the periplasm, again resulting in a piston-shift (Monzel and Unden, 
2015; Salvi et al., 2017). A piston-shift in the opposite direction, 
that is, toward the cytoplasm, is seen in activation of E. coli chemo-
receptors like Tar (reviewed in Parkinson et al., 2015).
Alternative motions in transmembrane signaling are diagonal 
scissoring displacements, for example, in the antimicrobial peptide 
and cation sensor PhoQ (Molnar et al., 2014), or helical rotations in 
kinases such as the quorum sensor AgrC of Staphylococcus aureus 
(Wang et al., 2014). Due to the diversity of conformational changes, 
there is currently no consensus model for transmembrane signal-
ing by histidine kinase, and it is likely that the different motions 
can work together within a single protein (Gushchin and Gordeliy, 
2017; Jacob-Dubuisson et al., 2018). Our data for BceS suggest that 
despite its unusual input mechanism via the BceAB transporter, 
transmembrane signaling is consistent with existing models of ki-
nase activation and occurs via an inward piston displacement. It is of 
course possible that further structural changes of higher complexity 
occur in BceS, or indeed within the BceS-BceB sensory complex. The 
unusual behavior of residue Y64 in the Scan-SCAM analyses may 
provide a first glimpse of such, but this is not currently resolved by 
our experimental data.
To complete signaling and kinase activation, the transmembrane 
motions will have to be translated into changes within the conserved 
kinase core to cause autophosphorylation, the common theme 
for which is helical rotation (Gushchin and Gordeliy, 2017; Jacob-
Dubuisson et al., 2018). In kinases where transmembrane signaling 
already occurs via rotation, the conformational change can likely 
be directly propagated to the core (Gushchin and Gordeliy, 2017). 
Kinases that signal via piston-displacements, however, require a 
means of converting this motion into a helical rotation. Recent 
crystallographic evidence has provided detailed molecular insights 
into how HAMP domains act as such converters of conformational 
change (Gushchin et al., 2017). While BceS lacks a bona fide HAMP 
domain, our results are in good agreement with such a mode of sig-
naling, where the piston-shift of transmembrane helix 2 is translated 
into helical rotations within the DHp domain via the intervening 
HAMP-like domain.
An earlier NMR study reported on the structure of the BceS-like 
kinase NsaS from S. aureus, which possesses a much shorter linker 
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region between its transmembrane and DHp domains (Bhate et al., 
2015). This linker region adopts a coiled-coil conformation instead of 
the HAMP-like fold of BceS. Inspection of kinase sequences in an ex-
isting collection of Bce-like resistance systems (Dintner et al., 2011) 
showed that the vast majority of these proteins contained the larger 
version of the linker (approximately 60 amino acids), and only a small 
number possessed short (around 20 amino acid) linkers with a pre-
dicted coiled-coil motif. BceS, therefore, appears to be the more 
typical subtype of this group of kinases than NsaS. Interestingly 
however, akin to the alternative helix packing mechanism proposed 
for HAMP domains (Hulko et al., 2006), activation of NsaS was also 
proposed to involve switching between helical packing states of the 
coiled-coil (Bhate et al., 2015). The molecular principles of activation 
may, therefore, be conserved between both subtypes of BceS-like 
kinases.
To further investigate the activation mechanism of BceS, we 
sought to force each of the conformational changes via amino acid 
substitutions. Charge repulsion at the core of the DHp domain to 
trigger helical rotation consistently led to kinase activation without 
a physiological stimulus (Figure 3). However, we were unable to ar-
tificially trigger activation through substitutions that should have 
induced piston displacements in the membrane (Figure S6) or in-
duced the active conformation of the HAMP domain (Figures 4 and 
S4). This is in contrast to studies of other kinases where such sub-
stitutions at least partially raises the basal activity (Appleman and 
Stewart, 2003; Matamouros et al., 2015; Monzel and Unden, 2015). 
In canonical histidine kinases, the input signal is detected directly, 
for example, through ligand binding, and it might be speculated that 
this might be relatively easy to mimic through amino acid substitu-
tions. In contrast, BceS-like proteins are subject to control by the 
transporter. It is conceivable that in such a kinase small changes in 
individual domains are insufficient for artificial activation, unless the 
DHp domain is directly manipulated. This may be supported by the 
MD simulations, which showed that the wild-type DHp domain does 
not by itself sample the conformational space observed in the active 
variant (Figure S3), implying the transporter may be required to pro-
vide the necessary force for transition to the active state.
Transporters are commonly used for accessory signaling con-
trol, but BceAB is unusual in that it is an activator of signaling, while 
most others act as repressors (Piepenbreier et al., 2017). We pre-
viously showed that transporter and kinase constitutively form 
a signaling complex in the membrane, irrespective of the inducer, 
bacitracin (Dintner et al., 2014). To activate the kinase proportion-
ally to transport activity, the transporter must, therefore, be able 
to directly influence kinase activity within this complex. When 
we first tested this in vitro, we noted that BceAB reduced kinase 
autophosphorylation in the OFF state, but could not explain the 
observation at the time (Dintner et al., 2014). Here, we now showed 
that the transporter indeed not only controls the ON but also the 
OFF state of BceS (Figure 6). We propose that through controlling 
both states of the kinase, the transporter is able to exert the close 
control needed to explain how signaling is maintained in proportion 
to transport activity over more than three orders of magnitude in 
antibiotic concentrations (Fritz et al., 2015). A crucial feature of the 
flux-sensing mechanism is an immediate reduction of signaling if 
transport activity is low, either because the antibiotic threat is over 
or because of sufficient detoxification capacity (Fritz et al., 2015). 
The active switching off of BceS by BceAB described here explains 
how this is realized on the molecular level. Complete control also 
allows the transporter to actively prevent spurious signaling by the 
two-component system. Finally, our mutagenesis analysis of BceAB 
revealed that evolution of the transporter itself appears to have ac-
tively avoided signaling at very low antibiotic concentrations, high-
lighting yet another level of cost reduction.
Taken together, we here present a molecular level model for ac-
tivation of antibiotic resistance based directly on the cell's need for 
protection, using a flux-sensing signaling strategy that employs mul-
tiple layers of active energy conservation to minimize fitness costs 
of resistance. The system is centered on two-component signaling, 
one of the most important regulatory features of bacteria. Our find-
ings should, therefore, have wide relevance and serve as a model 
for understanding how fine-tuned gene expression in bacteria can 
achieve an optimal cost-benefit balance.
4  | E XPERIMENTAL PROCEDURES
4.1 | Bacterial strains and growth conditions
All strains used in this study are listed in Table S1 and were routinely 
grown in Lysogeny Broth (LB; 10 g/L tryptone, 5 g/L yeast extract, 
5 g/L NaCl) at 37°C with aeration. Solid media contained 15 g/L 
agar. Selective media contained chloramphenicol (5 µg/ml), mac-
rolide-lincosamide-streptogramin B (erythromycin; 1 µg/ml, linco-
mycin; 25 µg/ml), spectinomycin (100 µg/ml), kanamycin (10 µg/ml), 
or ampicillin (100 µg/ml).
4.2 | DNA manipulation and strain construction
All primers and plasmids used in this study are given in Table S1. Site-
directed mutagenesis was carried out according to the manufactur-
er's instructions for the QuikChange II site-directed mutagenesis kit 
(Agilent Technologies), or by PCR-overlap extension (Ho et al., 1989). 
Bacillus subtilis transformations were carried out via natural compe-
tence as previously described (Harwood and Cutting, 1990). DNA 
for transformation was either provided as linearized plasmid DNA, 
or as genomic DNA from a B. subtilis strain already carrying the de-
sired genetic construct.
To allow manipulation of both bceS and bceAB sequences, an un-
marked deletion strain lacking all three genes (ΔbceSAB, SGB377) 
was constructed as described previously (Arnaud et al., 2004), em-
ploying plasmid pAK102. Strains lacking bceS only (ΔbceS; TMB1036) 
or bceAB only (bceAB::kan; TMB035 (Rietkötter et al., 2008)) were 
available from previous work. Signaling activity was assessed 
in strains harboring a chromosomally integrated transcriptional 
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reporter construct of the target promoter PbceA, fused to either 
luxABCDE (pSDlux101 (Kallenberg et al., 2013)) or lacZ (pER603 
(Rietkötter et al., 2008)). Details of the assays used are given below.
Genetic manipulation of bceS was performed using previously 
constructed plasmids as template. For Western blot detection, the 
construct pSD2E01 encoding BceS with a C-terminal octa-histidine 
tag (Pxyl-bceS
WT-His8 (Dintner et al., 2014)) was employed. Un-tagged 
constructs were derived from pAS719 (Pxyl-bceS
WT). Genetic manip-
ulation of bceAB was performed using the previously constructed 
plasmid pFK727, encoding BceAB with a C-terminal triple FLAG-tag 
on the permease (Pxyl-bceAB-FLAG3 (Kallenberg et al., 2013)). All 
constructs used in this study integrate stably and as a single copy 
into the B. subtilis W168 chromosome.
4.3 | Signaling activity assays
In strains carrying the PbceA-lacZ reporter, signaling was assessed fol-
lowing challenge of exponentially growing cells with Zn2+-bacitracin 
(bacitracin) and measured as β-galactosidase activity (expressed in 
Miller Units), as described previously (Rietkötter et al., 2008). For 
strains carrying the PbceA-luxABCDE reporter, luciferase activities 
were assayed using a Tecan Spark microplate reader controlled by 
SparkControlTM V2.1 software. Starter cultures were grown at 37°C 
in 2 ml of LB medium overnight, then diluted 1:1,000 into fresh 
medium before adding 100 µl into 96-well plates (black, clear flat 
bottoms; Corning). Samples were grown at 37°C with orbital agita-
tion at 180 rpm and allowed to achieve early exponential growth 
(OD600 0.3–0.4), before adding Zn
2+-bacitracin to a final concentra-
tion of 1 µg/ml unless otherwise indicated. OD600 and relative lu-
minescence units (RLU; integration time 1 second) were measured 
every 5 minutes and were background-corrected using values from 
LB-only wells. RLU was normalized for cell density (RLU OD–1). The 
reported values are steady-state activities achieved 60–75 minutes 
after bacitracin addition.
Cells were grown without the addition of xylose, as the basal 
activity of the promoter PxylA (Radeck et al., 2013), used to drive ex-
pression of the ectopic copies of bceS and/or bceAB, was sufficient 
to achieve full signaling activity. In strains containing the native copy 
of bceAB (ΔbceS background) signaling was induced with 10 µg/ml 
of Zn2+-bacitracin. In strains containing only the ectopic construct 
for BceAB production (ΔbceSAB background), signaling was induced 
with 1 µg/ml of Zn2+-bacitracin. These concentrations were estab-
lished in our earlier work as eliciting maximum signaling activity in 
the respective genetic backgrounds (Fritz et al., 2015).
4.4 | Bacitracin sensitivity assays
The sensitivity of B. subtilis strains to bacitracin was determined as 
described (Kallenberg et al., 2013), with minor modifications. Serial 
two-fold dilutions of Zn2+-bacitracin from 32 µg/ml to 0.5 µg/ml 
were prepared in Mueller-Hinton medium containing 0.2% (w/v) 
xylose to ensure maximal production of BceAB. For each concentra-
tion, 100 µl volumes in 96-well plates were inoculated 1:400 from 
overnight cultures grown in Mueller-Hinton medium with xylose 
and selective antibiotics. Each culture was scored for growth after 
20 to 24 hours of incubation at 37°C with aeration. The MIC was 
determined as the lowest bacitracin concentration where no visible 
growth was detected.
4.5 | Cysteine crosslinking in vivo
Cysteine crosslinking was assessed in strains carrying the ΔbceSAB 
deletion complemented with xylose-inducible ectopic copies of 
bceAB-FLAG3 and bceS-His8 with single-cysteine substitutions and 
the PbceA-lux reporter (SGB369 and derivatives). Starter cultures 
were grown in 2 ml of LB medium overnight at 37°C with agitation, 
then diluted 1:500 into 55 ml of fresh medium supplemented with 
0.02% (w/v) xylose. In mid-exponential growth (OD600 0.5–0.7), 
oxidative crosslinking of cysteine residues was triggered by addi-
tion of 250 µM of iodine for 15 minutes under continued incubation. 
Where required, cells were induced with 60 µg/ml Zn2+-bacitracin 
for 45 minutes prior to crosslinking. Crosslinking reactions were 
stopped with 20 mM N-ethylmaleimide (NEM) for 15 minutes 
under continued incubation. Cells were harvested by centrifugation 
(3,000g, 20 minutes, 4°C) and resuspended in 5 ml of ice cold lysis 
buffer (100 mM Tris–HCl [pH 8.0], 150 mM NaCl, 10% (w/v) glyc-
erol, 20 mM NEM). Cell disruption was achieved by at least three 
cycles of 15s sonication on ice with 15s rest. Debris was removed by 
centrifugation (3,000g, 20 minutes, 4°C), and membranes were col-
lected from supernatants by ultracentrifugation (150,000g, 1 hour, 
4°C). Membranes were resuspended in 50 µl lysis buffer, and ap-
proximately 150 mg protein per sample was mixed with non-reduc-
ing sample buffer (1 × final concentration; 1.5 M Tris–HCl [pH 6.8], 
30% (w/v) glycerol, 350 mM SDS, 0.12 mg/ml bromophenol blue) for 
SDS–PAGE and Western blot analysis (see below). For quantitation 
of band intensities Fiji (Schindelin et al., 2012) was used to obtain 
a profile plot of each lane, and the relative intensity of each band 
(monomer and dimer BceS) within the lane was expressed as a per-
centage of the total band intensities.
4.6 | Solvent accessibility of Cysteine residues 
in vivo (Scan-SCAM)
For solvent-accessibility tests in the second transmembrane helix of 
BceS, the ΔbceSAB deletion strain, complemented with xylose-in-
ducible ectopic copies of bceAB-FLAG3 and bceS-His8 and the PbceA-
lux reporter was employed. The bceS complementation construct 
was made cysteine-free via C45S/C198S/C259S substitutions, 
followed by introduction of single cysteines to be tested (strain 
SGB936 and derivatives). The same was done in the E115K/K116E 
variant to assess transmembrane topology in the active state (strain 
SGB951 and derivatives). Cultures were grown to mid-exponential 
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phase as described above. Cells were harvested, washed twice with 
50 mM HEPES buffer (pH 6.8) and resuspended in 5 ml of the same 
buffer. Water exposed (i.e., cytoplasmic) cysteine residues were 
masked with 40 mM N-Ethylmaleimide (NEM) for 1.5 hours at room 
temperature with shaking or left untreated. Masking reactions were 
stopped by three washes in cold (4°C) 50 mM HEPES buffer (pH 6.8). 
Cells were resuspended in 5 ml of ice cold lysis buffer, sonicated 
and membranes collected as above. Membranes were resuspended 
in 40 µl accessibility buffer (50 mM HEPES [pH 6.8], 1.3% (w/v) SDS). 
Cysteines that had not been masked with NEM in the first step were 
labeled with 5 mM methoxypolyethylene glycol maleimide (PEG-mal; 
Sigma-Aldrich) for 1.5 hours at room temperature with agitation. 
The reaction was stopped with 1 × LDS sample buffer (Expedeon) 
and 250 mM DTT and rested for 5 minutes. PEG-mal accessible and 
non-accessible BceS were analyzed by Western Blot.
4.7 | Western blot analysis
Protein samples (~150 µg) from in vivo crosslinking and Scan-SCAM 
were subjected to SDS–PAGE on RunBlueTM TEO-Tricine SDS 
mini gel in either Tris-Tricine-SDS (Sigma-Aldrich) or Teo-Tricine-
SDS (Expedeon) buffer, run for 50 minutes at 120V. Samples were 
transferred to polyvinylidene fluoride (PVDF) membranes (Merck 
Millipore, activated in 100% (v/v) methanol) in 1 × RunBlue SDS 
Running Buffer (Expedeon), 20% (v/v) methanol at 75 mA for 
70 minutes using a PerfectBlueTM SedecTM Semi-Dry Electroblotter 
(Peqlab). Membranes were blocked with 7.5% (w/v) skimmed milk 
powder in PBST (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4 [pH7.4], 0.1% (v/v) Tween 20), washed three times 
in PBST, and incubated with primary antibody (Penta·His Antibody, 
QIAGEN, 1:2,000 dilution) in 1% bovine serum albumin in PBST for 
2 hours at room temperature. Following three washes in PBST, in-
cubation with secondary antibody (Peroxidase-AffiniPure Goat 
Anti-Rabbit IgG, Jackson ImmunoResearch Europe Ltd, 1:4,000 dilu-
tion) was carried out in milk-PBST for 1h at room temperature, fol-
lowed by three final washes in PBST. Detection of proteins was by 
chemiluminescence using PierceTM ECL Western Blotting Substrate 
(Thermo Fisher Scientific Inc.) and a Qiagen CCD camera with Fusion 
software.
4.8 | Homology modeling
Homology models for the BceS HAMP and DHp domains (positions 
56 to 174), and for the C-terminal domain of BceAB (from posi-
tion 507) were generated using I-TASSER with default parameters 
(Yang et al., 2015; Zhang, 2008). The respective homology model 
with the highest C-score was selected, and the top-ranking struc-
tural analog from PDB identified by I-TASSER was noted for refer-
ence. For quality control, the resulting homology model for BceS 
was compared to its closest structural analog, PDB 3RZW, using the 
TM-align structural alignment programme implemented in I-TASSER 
(Yang et al., 2015; Zhang, 2008). The obtained TM-score was 0.771 
(where > 0.5 assumes the same fold), with a root mean square de-
viation (RMSD) of 1.68 Å between the structurally aligned residues. 
The homology model was analyzed for Ramachandran outliers using 
MolProbity (Williams et al., 2017). Eight outliers were identified, all 
within unstructured loop regions of the model: six fall in the loop 
connecting the two helices in the HAMP-like domain, and two in the 
loop connecting the DHp domain helices. The homology model was, 
therefore, regarded as a plausible representation of the BceS struc-
ture, but with some uncertainty in the linking loops between helical 
segments.
4.9 | Gaussian accelerated molecular dynamics 
(GaMD) simulations
A homology model of the cytoplasmic region of BceS consisting of 
the DHp and ATPase domains was constructed using I-TASSER as 
before (Yang et al., 2015; Zhang, 2008). The HAMP-like domain was 
excluded due to low sequence homology with conventional HAMP 
domains. The approximate orientation of each BceS monomer with 
respect to one another was predicted based on cysteine crosslinking 
data (Figure 2) and further refined using Z-Dock to perform rigid body 
protein-protein docking (Pierce et al., 2014), with subsequent side 
chain rotamers optimized using SCWRL4 (Krivov et al., 2009). After 
MD equilibration of the dimer model (see below), no Ramachandran 
outliers were present in the loop connecting the DHp domain helices 
or elsewhere (only Gly262, located in a flexible loop in the ATPase 
domain, was just outside the “allowed region”). The N-terminus of 
the DHp domain of each monomer was acetylated to cap the α-helix 
and prevent having a positive charge at the termini. ATP was then 
docked into each ATP-binding site using AutoDock Vina (exhaustive-
ness set to 32) (Trott and Olson, 2010). The generated model of BceS 
was then manually modified to construct the E115K/K116E variant. 
All residues were modeled in their standard protonation states, with 
His108 and His124 singly protonated on the Nδ1 nitrogen, and all 
other His singly protonated on the Nε2 nitrogen (as indicated by hy-
drogen bonding networks). Both systems were solvated in an octa-
hedral water box such that no protein/substrate atom was within 
10 Å of the box boundaries, with Na+ or Cl− counter ions added 
as necessary to ensure an overall neutral charge. MD simulations 
were performed using GPU accelerated Amber16, with the ff14SB 
force field and TIP3P water model used to describe protein and 
water molecules respectively. Parameters for ATP were taken from 
a study by Meagher and colleagues (Meagher et al., 2003). Following 
a minimization, heating, NVT and NPT equilibration procedure (de-
scribed below), GaMD simulations were done in the NVT ensemble 
at 300 K (Miao et al., 2015), with a boost potential applied to both 
the total system potential energy as well as the dihedral potential 
energies (see also GaMD settings in Table S3). To prepare for pro-
duction GaMD simulations, a 12 ns long conventional MD run was 
used to obtain maximum, minimum, average and standard deviation 
of the system potential energies. Following this, a 66 ns long run 
16  |     KOH et al.
was used to update the above parameters (updated every 600 ps) to 
ensure converged GaMD production parameters. Production GaMD 
simulations were then run for 4 × 500 ns, using different random 
seeds for each replica. MD simulations were run using a 2 fs time 
step with the SHAKE algorithm applied to any bond containing a hy-
drogen atom. An 8 Å direct space non-bonded cut-off was applied 
with long-range electrostatics evaluated using the particle mesh 
Ewald algorithm (Darden et al., 1993). Temperature was regulated 
using Langevin temperature control (collision frequency of 1 ps−1). 
All MD and GaMD simulations were performed with a 10 kcal/mol 
restraint on the Phi and Psi dihedrals between the acetyl and first 
N-terminal residue, to prevent the α-helix fraying. Principal compo-
nent analysis (PCA) and other trajectory analyses were performed 
within CPPTRAJ (Roe and Cheatham, 2013), on the Cα atoms of the 
DHp domain residues. PCA was performed on the trajectories after 
constructing an average structure of all four simulations combined. 
Reweighting of PCA and distance measurements (to obtain PMFs) 
was performed using the “PyReweighting” toolkit (Miao et al., 2014).
To equilibrate structures for GaMD simulations, the following 
procedure was performed. Minimization of all hydrogen atoms and 
solvent molecules was done using 500 steps of steepest descent 
followed by 500 steps of conjugate gradient. To keep all other 
atoms (i.e., the protein heavy atoms) in place during the minimiza-
tion, 10 kcal/mol Å−1 positional restraints were applied. Retaining 
the positional restraints on all protein heavy atoms, the system was 
then heated rapidly from 50 K to 300 K in the NVT ensemble over 
the course of 200 ps. This system was again minimized for a further 
500 steps of steepest descent followed by 500 steps of conjugate 
gradient, this time only applying positional restraints (of size 5 kcal/
mol Å−1) to the Cα carbon atoms. These Cα restraints were retained 
as the system was again heated from 25 K to 300 K over the course 
of 50 ps in the NVT ensemble. Simulations were then performed in 
the NPT ensemble (1 atm, 300 K), first gradually reducing the 5 kcal/
mol Å−1 Cα carbon restraints over the course of 50 ps of simulation 
time. This was done in five steps (5, 4, 3, 2, 1 kcal/mol Å−1) of 10 ps 
each. A final 20 ns long MD simulation was then performed, in which 
no restraints were used, to equilibrate the box size. All dynamics 
steps used the SHAKE algorithm. Simulations performed in the 
NVT ensemble used Langevin temperature control (with a collision 
frequency of 1 ps−1) and a simulation time-step of 1 fs. Simulations 
performed in the NPT ensemble again used Langevin temperature 
control (collision frequency of 1 ps−1) and a Berendsen barostat (1 ps 
pressure relaxation time), with a simulation time-step of 2 fs.
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